Get the Stockscreener App
4.74
1.07%
0.05
After Hours:
4.76
0.02
+0.42%
Niagen Bioscience Inc stock is traded at $4.74, with a volume of 995.69K.
It is up +1.07% in the last 24 hours and down -0.84% over the past month.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
See More
Previous Close:
$4.69
Open:
$4.75
24h Volume:
995.69K
Relative Volume:
0.88
Market Cap:
$379.58M
Revenue:
$129.42M
Net Income/Loss:
$17.38M
P/E Ratio:
23.20
EPS:
0.2043
Net Cash Flow:
$13.15M
1W Performance:
+3.04%
1M Performance:
-0.84%
6M Performance:
-36.80%
1Y Performance:
-25.88%
1-Day Range:
$4.72
$4.865
1-Week Range:
$4.355
$4.865
52-Week Range:
$4.16
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Name
Niagen Bioscience Inc
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
4.74 | 375.58M | 129.42M | 17.38M | 13.15M | 0.2043 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Initiated | Canaccord Genuity | Buy |
| Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Oct-16-19 | Initiated | Oppenheimer | Outperform |
| Feb-14-19 | Initiated | B. Riley FBR | Buy |
| Nov-27-17 | Resumed | H.C. Wainwright | Buy |
| Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Niagen Bioscience Inc Stock (NAGE) Latest News
Niagen Bioscience: How Its Shift To Telehealth Makes It A Strong Buy (NASDAQ:NAGE) - Seeking Alpha
Niagen Bioscience And 2 Additional Promising Penny Stocks For Your Consideration - Yahoo Finance
Value Recap: Will Niagen Bioscience Inc stock go up in YEAR2026 Setups & Free High Return Stock Watch Alerts - baoquankhu1.vn
Q3 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
Aug Shorts: Should I trade or invest in FEIMEarnings Performance Report & Smart Swing Trading Alerts - baoquankhu1.vn
USP adopts inaugural monograph for NRCl following Niagen Bioscience analytical partnership - Traders Union
Published on: 2026-04-10 09:01:33 - baoquankhu1.vn
Niagen Bioscience Establishes First-Ever USP Monograph for Patented Nicotinamide Riboside Chloride - National Today
Niagen Bioscience (NAGE) Achieves USP Monograph for Key Ingredient - GuruFocus
Q4 2025 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus
Niagen Bioscience secures USP monograph for Nicotinamide Riboside Chloride in dietary supplements - Traders Union
Niagen ingredient receives U.S. Pharmacopeia monograph - Investing.com
Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen - Business Wire
Aug Outlook: Is Niagen Bioscience Inc a cyclical or defensive stock2026 Volume Leaders & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Niagen Bioscience Inc. (NAGE): Among the 12 Cheap Penny Stocks to Invest In Now - Yahoo Finance
NAGE SEC FilingsNiagen Bioscience, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NAGE Technical Analysis | Trend, Signals & Chart Patterns | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
- Cyprus Shipping News - Cyprus Shipping News
Bond Watch: Will Niagen Bioscience Inc stock go up in YEAR2026 Growth vs Value & AI Driven Stock Reports - baoquankhu1.vn
Weekly Recap: Is Niagen Bioscience Inc stock overvalued or fairly priced2026 WrapUp & Verified Entry Point Signals - baoquankhu1.vn
NAGE Stock Price, Quote & Chart | NIAGEN BIOSCIENCE INC (NASDAQ:NAGE) - ChartMill
Skincare-Focused Innovation Labs - Trend Hunter
JPMorgan Chase & Co. Makes New $3.68 Million Investment in Niagen Bioscience, Inc. $NAGE - MarketBeat
Niagen Bioscience soars 38% on blowout Q4 results - Investing.com
Tru Niagen gains traction with expert backing, Niagen Bioscience expands reach - Traders Union
Earnings call transcript: Niagen Bioscience’s Q4 2025 revenue grows 16% - Investing.com
Canaccord Lowers Niagen Bioscience, Inc. (NAGE) PT on Updated Forecasts Following Q4 Results - Insider Monkey
Aug Wrap: How do insiders feel about Niagen Bioscience IncMarket Weekly Review & Daily Entry Point Trade Alerts - baoquankhu1.vn
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpa World, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas - marketscreener.com
Niagen Bioscience partners with OneSpaWorld for cruise ship clinics By Investing.com - Investing.com India
12 Penny Stocks with Insider Buying in 2026 - Insider Monkey
Niagen Bioscience And OneSpaWorld Launch Niagen IV Across Medi-Spa Clinics On Cruise Ships - marketscreener.com
Niagen Bioscience's (NAGE) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat
Niagen Bioscience partners with OneSpaWorld for cruise ship clinics - Investing.com
Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas - Business Wire
Niagen Bioscience, Inc. (NASDAQ:NAGE) Short Interest Down 13.6% in March - MarketBeat
Niagen Bioscience (NAGE) price target decreased by 13.92% to 13.87 - MSN
Niagen Bioscience (NASDAQ:NAGE) Upgraded at Wall Street Zen - MarketBeat
New Highs: How is Niagen Bioscience Inc managing supply chain issuesTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
How The Niagen Bioscience (NAGE) Story Is Shifting Around Price Targets And Injectables Potential - Yahoo Finance
Street Watch: Is Niagen Bioscience Inc stock risky to hold nowMarket Activity Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Niagen Bioscience doubles share buyback program to $20 million By Investing.com - Investing.com Canada
Niagen Bioscience Increases Share Repurchase Program to $20 Million - PharmiWeb.com
Niagen Bioscience Doubles Share Repurchase Authorization to $20M - TipRanks
Niagen Bioscience doubles share buyback program to $20 million - Investing.com
Niagen Bioscience raises share buyback authorization to $20M, $2.6M repurchased to date - TradingView
Niagen Bioscience (NAGE) boosts share repurchase authorization to $20 million - Stock Titan
Will Niagen Bioscience Inc outperform its industry peers2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Niagen Bioscience, Inc. announces an Increase in Equity Buyback. - marketscreener.com
Niagen Bioscience Inc Stock (NAGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):